Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 40 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

5 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

7 recruiting1 with results

Enrollment Performance

Analytics

N/A

14(56.0%)

Phase 2

5(20.0%)

Phase 4

3(12.0%)

Phase 3

2(8.0%)

Phase 1

1(4.0%)

25Total

N/A(14)

Phase 2(5)

Phase 4(3)

Phase 3(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (40)

Showing 20 of 40 trials

NCT06417476Phase 2Active Not Recruiting

Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

Role: collaborator

NCT07412171Phase 2Not Yet Recruiting

NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC

Role: collaborator

NCT07343102Completed

Incidence of Hemocompatibility Events With or Without Aspirin in Patients With CH-VAD

Role: collaborator

NCT07249281Recruiting

MR Microstructural Imaging for Prostate Cancer Diagnosis

Role: collaborator

NCT07238959Not Yet Recruiting

Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer

Role: collaborator

NCT07195617Not ApplicableNot Yet Recruiting

Clinical Study on Evaluating the Safety and Effectiveness of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Third-line or Above Treatment

Role: collaborator

NCT07185308Not ApplicableNot Yet Recruiting

Postbiotics Ameliorate Cachexia in Patients With Non-small-cell Lung Cancer

Role: collaborator

NCT07176754Not ApplicableNot Yet Recruiting

TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.

Role: collaborator

NCT06589154Completed

The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis

Role: collaborator

NCT07096219Enrolling By Invitation

Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study

Role: collaborator

NCT04532606Phase 4Recruiting

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Role: collaborator

NCT07068425Not Yet Recruiting

Longitudinal Observational Study on Immune Thrombocytopenia

Role: collaborator

NCT06078930Recruiting

Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms

Role: collaborator

NCT06498206Not ApplicableRecruiting

AR Training Versus Patching in Unilateral Amblyopia